A detailed history of Black Rock Inc. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,687,619 shares of ALXO stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,687,619
Previous 2,221,561 20.98%
Holding current value
$3.57 Million
Previous $24.8 Million 34.57%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.84 - $17.56 $2.72 Million - $8.18 Million
466,058 Added 20.98%
2,687,619 $16.2 Million
Q1 2024

May 10, 2024

SELL
$10.95 - $16.79 $148,175 - $227,202
-13,532 Reduced 0.61%
2,221,561 $24.8 Million
Q4 2023

Feb 13, 2024

BUY
$4.81 - $15.38 $1.89 Million - $6.03 Million
392,074 Added 21.27%
2,235,093 $33.3 Million
Q3 2023

Nov 13, 2023

BUY
$4.19 - $7.35 $227,345 - $398,803
54,259 Added 3.03%
1,843,019 $8.85 Million
Q2 2023

Aug 11, 2023

BUY
$4.37 - $9.56 $524,994 - $1.15 Million
120,136 Added 7.2%
1,788,760 $13.4 Million
Q1 2023

May 12, 2023

SELL
$4.52 - $11.71 $146,728 - $380,130
-32,462 Reduced 1.91%
1,668,624 $7.54 Million
Q4 2022

Feb 13, 2023

BUY
$9.51 - $12.95 $291,804 - $397,357
30,684 Added 1.84%
1,701,086 $19.2 Million
Q3 2022

Nov 14, 2022

BUY
$8.23 - $15.14 $66,827 - $122,936
8,120 Added 0.49%
1,670,402 $16 Million
Q2 2022

Aug 12, 2022

BUY
$5.89 - $19.46 $1.81 Million - $5.97 Million
306,804 Added 22.63%
1,662,282 $13.4 Million
Q1 2022

May 12, 2022

BUY
$13.65 - $22.06 $203,480 - $328,848
14,907 Added 1.11%
1,355,478 $22.9 Million
Q4 2021

Feb 10, 2022

SELL
$21.49 - $74.4 $562,823 - $1.95 Million
-26,190 Reduced 1.92%
1,340,571 $28.8 Million
Q3 2021

Nov 09, 2021

BUY
$52.51 - $80.91 $6.01 Million - $9.26 Million
114,456 Added 9.14%
1,366,761 $101 Million
Q2 2021

Aug 11, 2021

BUY
$52.2 - $75.23 $65.4 Million - $94.2 Million
1,252,305 New
1,252,305 $68.5 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $54.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.